Capros is developed from Phyllanthus emblica, the
Capros has a high ORAC value of nearly 1,800, which is certainly compelling, but the in vivo results really tell the whole story, according to Dr. Runa Ghosh, PhD, Managing Director of R&D at Natreon, Inc. An in vivo Capros study shows that this ingredient has comparable antioxidant potential based on well known in vivo radical scavenging assays. Compared specifically with extracts of pine bark, grape seed and pomegranate, all popular ingredients on the market, the resulting values for Capros showed significantly better defense against chronic oxidative stress with no adverse effects. The model design included controls and was a severe challenge to the mice, based on 28-day administration of toxic potassium dichromate, known to produce oxidative stress. The assays were made on samples taken from the brain, liver and plasma of the animals. Given these results, Capros shows promise as a synergistic antioxidant ingredient.
Capros is made by Natreon, Inc., which brings together the powers of ancient medicine with the support and backing of modern science and clinical research. As a leading research company dedicated to developing the novel compounds revered in Ayurvedic medicine, an ancient form of treatment practiced daily by millions of individuals worldwide, Natreon, Inc. is committed to using modern technology and science to support these safe and effective ancient treatments for today’s contemporary world.
As of March 2009, we could not find human studies with
About Natreon, Inc.:
Founded in 1998, Natreon focuses on developing novel compounds extracted from the traditional botanicals of Ayurvedic medicine. With US headquarters in New Brunswick, NJ and state of the art research facilities in India, Natreon has created a broad portfolio of products and technologies, with compelling, intellectual property, that can serve unmet nutritional supplement, functional food, and pharmaceutical market needs.
cdp choline supplement benefit side effects